According to the FMI report, the global clinical trials market was valued over US$ 90 Bn in 2019 and is projected to expand at a CAGR of ~4% from 2019 to 2029. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global clinical trials …
Continue reading “Clinical Trials Market Study: An Emerging Hint of Opportunity by 2029”